The Block Firm is investigating a potential class action lawsuit against MiMedx Group, Inc., the maker of the AXIOFILL wound treatment. According to a recently released FDA Warning Letter, MiMedx Group has been selling AXIOFILL without proper approval for safety and efficacy. Additionally, FDA determined that MiMedx Group has been violating federal safety standards known as Current Good Manufacturing Practices or CGMPs, which help ensure that medical products are sterile and safe.
When companies violate federal drug and device safety rules, they put patients at risk and distort the market for health care.
If you were exposed to AXIOFILL, you may have a claim for compensation. Please contact the experienced attorneys at The Block Firm to learn more about your potential legal rights.
